An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women

Polis, 2014, Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence, Contraception, 90, 360, 10.1016/j.contraception.2014.07.009

Butler, 2013, Modelling the global competing risks of a potential interaction between injectable hormonal contraception and HIV risk, AIDS, 27, 105, 10.1097/QAD.0b013e32835a5a52

Alkema, 2016, Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN Maternal Mortality Estimation Inter-Agency Group, Lancet, 387, 462, 10.1016/S0140-6736(15)00838-7

Schelar, 2016, Multipurpose prevention technologies for sexual and reproductive health: mapping global needs for introduction of new preventive products, Contraception, 93, 32, 10.1016/j.contraception.2015.09.002

Blish, 2011, Hormonal contraception and HIV-1 transmission, Am J Reprod Immunol, 65, 302, 10.1111/j.1600-0897.2010.00930.x

Hel, 2010, Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection, Endocr Rev, 31, 79, 10.1210/er.2009-0018

Achilles, 2013, The complexity of contraceptives: understanding their impact on genital immune cells and vaginal microbiota, AIDS, 27, S5, 10.1097/QAD.0000000000000058

Hickey, 2016, Critical review: mechanisms of HIV transmission in Depo-Provera users: the likely role of hypoestrogenism, J Acquir Immune Defic Syndr, 71, 1, 10.1097/QAI.0000000000000805

Fichorova, 2015, The contribution of cervicovaginal infections to the immunomodulatory effects of hormonal contraception, MBio, 6, e00221, 10.1128/mBio.00221-15

Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, PLoS Med, 6, e1000097, 10.1371/journal.pmed.1000097

Polis, 2013, Assessing the effect of hormonal contraception on HIV acquisition in observational data: challenges and recommended analytic approaches, AIDS, 27, S35, 10.1097/QAD.0000000000000036

Hernan, 2010, The hazards of hazard ratios, Epidemiology, 21, 13, 10.1097/EDE.0b013e3181c1ea43

DerSimonian, 1986, Meta-analysis in clinical trials, Control Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2

Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557

Van Damme, 2012, Preexposure prophylaxis for HIV infection among African women, N Engl J Med, 367, 411, 10.1056/NEJMoa1202614

Masese, 2015, Changes in the contribution of genital tract infections to HIV acquisition among Kenyan high-risk women from 1993 to 2012, AIDS, 29, 1077, 10.1097/QAD.0000000000000646

Ralph, 2015, Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies, Lancet Infect Dis, 15, 181, 10.1016/S1473-3099(14)71052-7

Brind, 2015, Risk of HIV infection in depot-medroxyprogesterone acetate (DMPA) users: a systematic review and meta-analysis, Issues Law Med, 30, 129

Crook, 2014, Injectable and oral contraceptives and risk of HIV acquisition in women: an analysis of data from the MDP301 trial, Hum Reprod, 29, 1810, 10.1093/humrep/deu113

Dube, 2014, HIV incidence in a cohort of women at higher risk in Beira, Mozambique: prospective study 2009–2012, PLoS One, 9, e84979, 10.1371/journal.pone.0084979

Feldblum, 2014, HIV prevalence and incidence in a cohort of women at higher risk for HIV acquisition in Chokwe, southern Mozambique, PLoS One, 9, e97547, 10.1371/journal.pone.0097547

Kapiga, 2013, The epidemiology of HIV and HSV-2 infections among women participating in microbicide and vaccine feasibility studies in Northern Tanzania, PLoS One, 8, e68825, 10.1371/journal.pone.0068825

McKinnon, 2015, Risk factors for HIV acquisition in a prospective Nairobi-based female sex worker cohort, AIDS Behav, 19, 2204, 10.1007/s10461-015-1118-7

Morrison, 2015, Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis, PLoS Med, 12, 1, 10.1371/journal.pmed.1001778

Wall, 2015, Hormonal contraception does not increase women's HIV acquisition risk in Zambian discordant couples, 1994–2012, Contraception, 91, 480, 10.1016/j.contraception.2015.02.004

Byrne, 2016, Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in South African women: a prospective cohort study, Lancet Infect Dis, 16, 441, 10.1016/S1473-3099(15)00429-6

Balkus, 2016, Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial, Contraception, 93, 25, 10.1016/j.contraception.2015.10.010

Noguchi, 2015, Risk of HIV-1 acquisition among women who use different types of injectable progestin contraception in South Africa: a prospective cohort study, Lancet HIV, 2, e279, 10.1016/S2352-3018(15)00058-2

Wand, 2012, The effects of injectable hormonal contraceptives on HIV seroconversion and on sexually transmitted infections, AIDS, 26, 375, 10.1097/QAD.0b013e32834f990f

Kaul, 2004, Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial, JAMA, 291, 2555, 10.1001/jama.291.21.2555

Vallely, 2007, Microbicides development program, Tanzania-baseline characteristics of an occupational cohort and reattendance at 3 months, Sex Transm Dis, 34, 638, 10.1097/OLQ.0b013e3180325120

Vandepitte, 2011, HIV and other sexually transmitted infections in a cohort of women involved in high-risk sexual behavior in Kampala, Uganda, Sex Transm Dis, 38, 316, 10.1097/OLQ.0b013e3182099545

Abdool Karim, 2010, Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women, Science, 329, 1168, 10.1126/science.1193748

Baeten, 2007, Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women, AIDS, 21, 1771, 10.1097/QAD.0b013e328270388a

Bulterys, 1994, Incident HIV-1 infection in a cohort of young women in Butare, Rwanda, AIDS, 8, 1585, 10.1097/00002030-199411000-00010

Feldblum, 2010, Baseline factors associated with incident HIV and STI in four microbicide trials, Sex Transm Dis, 37, 594, 10.1097/OLQ.0b013e3181e15f0b

Heffron, 2012, Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study, Lancet Infect Dis, 12, 19, 10.1016/S1473-3099(11)70247-X

Heffron, 2012, Authors’ reply: use of hormonal contraceptives and risk of HIV-1 transmission, Lancet Infect Dis, 12, 510, 10.1016/S1473-3099(12)70153-6

Kapiga, 1998, The incidence of HIV infection among women using family planning methods in Dar es Salaam, Tanzania, AIDS, 12, 75, 10.1097/00002030-199801000-00009

Kiddugavu, 2003, Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda, AIDS, 17, 233, 10.1097/00002030-200301240-00014

Kilmarx, 1998, HIV-1 seroconversion in a prospective study of female sex workers in northern Thailand: continued high incidence among brothel-based women, AIDS, 12, 1889, 10.1097/00002030-199814000-00021

Kleinschmidt, 2007, Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort, Contraception, 75, 461, 10.1016/j.contraception.2007.02.002

Kumwenda, 2008, HIV-1 incidence among women of reproductive age in Malawi, Int J STD AIDS, 19, 339, 10.1258/ijsa.2007.007165

Laga, 1993, Nonulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study, AIDS, 7, 95, 10.1097/00002030-199301000-00015

Lutalo, 2013, Effects of hormonal contraceptive use on HIV acquisition and transmission among HIV-discordant couples, AIDS, 27, S27, 10.1097/QAD.0000000000000045

McCoy, 2013, Oral and injectable contraception use and risk of HIV acquisition among women in sub-Saharan Africa, AIDS, 27, 1001, 10.1097/QAD.0b013e32835da401

Morrison, 2010, Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling, AIDS, 24, 1778, 10.1097/QAD.0b013e32833a2537

Morrison, 2007, Hormonal contraception and the risk of HIV acquisition, AIDS, 21, 85, 10.1097/QAD.0b013e3280117c8b

Lavreys, 2004, Hormonal contraception and risk of HIV-1 acquisition: results of a 10-year prospective study, AIDS, 18, 695, 10.1097/00002030-200403050-00017

Morrison, 2012, Hormonal contraception and the risk of HIV acquisition among women in South Africa, AIDS, 26, 497, 10.1097/QAD.0b013e32834fa13d

Myer, 2007, Prospective study of hormonal contraception and women's risk of HIV infection in South Africa, Int J Epidemiol, 36, 166, 10.1093/ije/dyl251

Plummer, 1991, Cofactors in male-female sexual transmission of human immunodeficiency virus type 1, J Infect Dis, 163, 233, 10.1093/infdis/163.2.233

Reid, 2010, Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women, J Acquir Immune Defic Syndr, 53, 606, 10.1097/QAI.0b013e3181bc4869

Saracco, 1993, Man-to-woman sexual transmission of HIV: longitudinal study of 343 steady partners of infected men, J Acquir Immune Defic Syndr, 6, 497, 10.1097/00126334-199305000-00010

Watson-Jones, 2009, Risk factors for HIV incidence in women participating in an HSV suppressive treatment trial in Tanzania, AIDS, 23, 415, 10.1097/QAD.0b013e32831ef523

Sinei, 1996, Contraceptive use and HIV infection in Kenyan family planning clinic attenders, Int J STD AIDS, 7, 65, 10.1258/0956462961917104

Ungchusak, 1996, Determinants of HIV infection among female commercial sex workers in northeastern Thailand: results from a longitudinal study, J Acquir Immune Defic Syndr Hum Retrovirol, 12, 500, 10.1097/00042560-199608150-00010

Wasserstein, 2016, The ASA's statement on p-values: context, process, and purpose, Am Stat, 70, 129, 10.1080/00031305.2016.1154108

McCoy, 2014, Are hormonal contraceptive users more likely to misreport unprotected sex? Evidence from a biomarker validation study in Zimbabwe, AIDS Behav, 18, 2259, 10.1007/s10461-014-0741-z

Smit, 2001, Counting the costs: comparing depot medroxyprogesterone acetate and norethisterone oenanthate utilisation patterns in South Africa, BMC Health Serv Res, 1, 4, 10.1186/1472-6963-1-4

Morroni, 2006, Preferences between injectable contraceptive methods among South African women, Contraception, 73, 598, 10.1016/j.contraception.2006.01.005

Grabowski, 2015, Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda, Lancet Glob Health, 3, e478, 10.1016/S2214-109X(15)00086-8

Borgdorff, 2015, The impact of hormonal contraception and pregnancy on sexually transmitted infections and on cervicovaginal microbiota in African sex workers, Sex Transm Dis, 42, 143, 10.1097/OLQ.0000000000000245

Senn, 2009, Overstating the evidence: double counting in meta-analysis and related problems, BMC Med Res Methodol, 9, 10, 10.1186/1471-2288-9-10

Egger, 1998, Spurious precision? Meta-analysis of observational studies, BMJ, 316, 140, 10.1136/bmj.316.7125.140

Polis, 2013, Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence, Lancet Infect Dis, 13, 797, 10.1016/S1473-3099(13)70155-5

Rodriguez, 2012, Evaluating the competing risks of HIV acquisition and maternal mortality in Africa: a decision analysis, BJOG, 119, 1067, 10.1111/j.1471-0528.2012.03402.x

Sokat, 2015, Implications of switching away from injectable hormonal contraceptives on the HIV epidemic, Socioecon Plann Sci, 52, 1, 10.1016/j.seps.2015.08.001

Jain, 2012, Hormonal contraception and HIV acquisition risk: implications for individual users and public policies, Contraception, 86, 645, 10.1016/j.contraception.2012.03.008

Jain, 2013, Erratum to: Hormonal contraception and HIV acquisition risk: implications for individual users and public policies, Contraception, 88, 195, 10.1016/j.contraception.2013.01.002

Martin, 1998, Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1, J Infect Dis, 178, 1053, 10.1086/515654